Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study

  • Piotr Rutkowski1Email author,
  • Elżbieta Bylina1,
  • Anna Klimczak1,
  • Tomasz Świtaj1,
  • Sławomir Falkowski1,
  • Jacek Kroc2,
  • Iwona Ługowska1,
  • Magdalena Brzeskwiniewicz3,
  • Wojciech Melerowicz4,
  • Czesław Osuch5,
  • Ewa Mierzejewska6,
  • Kacper Wasielewski3,
  • Agnieszka Woźniak7,
  • Urszula Grzesiakowska8,
  • Zbigniew I Nowecki9,
  • Janusz A Siedlecki10 and
  • Janusz Limon3
BMC Cancer201212:107

DOI: 10.1186/1471-2407-12-107

Received: 27 November 2011

Accepted: 22 March 2012

Published: 22 March 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
27 Nov 2011 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
24 Jan 2012 Reviewed Reviewer Report - Charlotte Benson
30 Jan 2012 Reviewed Reviewer Report - Mikael Eriksson
4 Mar 2012 Author responded Author comments - Piotr Rutkowski
Resubmission - Version 3
4 Mar 2012 Submitted Manuscript version 3
Publishing
22 Mar 2012 Editorially accepted
22 Mar 2012 Article published 10.1186/1471-2407-12-107

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article.. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
(2)
Pfizer Poland
(3)
Department of Biology and Genetics, Medical University of Gdansk
(4)
GreaterPoland Oncological Center
(5)
Department of General Surgery, Jagiellonian University, Medical Faculty
(6)
Department of Biostatistics, Institute of Mother and Child
(7)
Laboratory of Experimental Oncology and Department of General Medical Oncology, KU Leuven and University Hospital
(8)
Department of Radiology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
(9)
Department of Gastrointestinal Tumors, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology
(10)
Department of Molecular Biology, Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology

Advertisement